We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
99 hedge funds and large institutions have $101M invested in Puma Biotechnology in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
396% more call options, than puts
Call options by funds: $417K | Put options by funds: $84K
30% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 20
27% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 26
6% more funds holding
Funds holding: 93 → 99 (+6)
2.52% more ownership
Funds ownership: 61.7% → 64.22% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
36% less capital invested
Capital invested by funds: $158M → $101M (-$56.7M)
Holders
99
Holders Change
+6
Holders Change %
+6.45%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
26
Increased
33
Reduced
26
Closed
20
Calls
$417K
Puts
$84K
Net Calls
+$333K
Net Calls Change
-$4.1M
Top Buyers
| 1 |
BlackRock
New York
|
+$8.58M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.18M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$1.61M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.5M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.26M |
Top Sellers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$8.74M |
| 2 |
Jane Street
New York
|
-$1.82M |
| 3 |
Morgan Stanley
New York
|
-$1.29M |
| 4 |
Goldman Sachs
New York
|
-$1.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$905K |
